{"id":{"repo_id":"mtu","oai_identifier":"oai:digitalcommons.mtu.edu:etdr-1483"},"canonical_url":"https://search.ndltd.org/etd/mtu/oai:digitalcommons.mtu.edu:etdr-1483","repository":{"repo_id":"mtu","name":"Michigan Technological University","base_url":"https://digitalcommons.mtu.edu/do/oai/"},"display":{"title":"IDENTIFICATION OF NITRIC-OXIDE DEGRADATION PRODUCTS OF ASCORBIC ACID","abstract":"Nitric oxide (NO) has been shown to possess many Anti-inflammatory effects. Ascorbic acid which is naturally present in human body is known to react with S-nitrosothiols (RSNO) directly to reduce RSNO to NO and produce free thiol groups, if present in more than millimolar concentration. Higher concentration of ascorbic acid is required because the reduction of RSNO is not caused by ascorbate instead, but instead a decomposed product of ascorbic acid. S-Nitroso-N-Acetylpenicillamine is used as an NO donor. An HPLC method is used for determination of the degradation product of ascorbic acid and simultaneously identifying the compound responsible for NO production from RSNO by running the compound through Nitric Oxide Analyzer. Once the compound is identified it has a potential medical use for NO production. For example, it could provide a means that initiates RSNO decomposition in polymeric biomaterials. Thus, increasing the functionality of the medical device coated with such materials and preventing thrombus formation.","abstract_html":"Nitric oxide (NO) has been shown to possess many Anti-inflammatory effects. Ascorbic acid which is naturally present in human body is known to react with S-nitrosothiols (RSNO) directly to reduce RSNO to NO and produce free thiol groups, if present in more than millimolar concentration. Higher concentration of ascorbic acid is required because the reduction of RSNO is not caused by ascorbate instead, but instead a decomposed product of ascorbic acid. S-Nitroso-N-Acetylpenicillamine is used as an NO donor. An HPLC method is used for determination of the degradation product of ascorbic acid and simultaneously identifying the compound responsible for NO production from RSNO by running the compound through Nitric Oxide Analyzer. Once the compound is identified it has a potential medical use for NO production. For example, it could provide a means that initiates RSNO decomposition in polymeric biomaterials. Thus, increasing the functionality of the medical device coated with such materials and preventing thrombus formation.","abstract_has_math":false,"creators":["Kolipaka, Sushant Satyanarayan"],"institution":null,"degree_name":"Master of Science in Biomedical Engineering (MS)","degree_level":"Open Access Master's Thesis","degree_discipline":"Department of Biomedical Engineering","degree_department":null,"school":null,"contributors":["Megan Frost"],"advisors":[],"committee_chairs":[],"committee_members":["Martin Thompson","Smitha Rao"],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:17:02Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.mtu.edu/etdr/442"],"render_values":[{"text":"https://digitalcommons.mtu.edu/etdr/442","href":"https://digitalcommons.mtu.edu/etdr/442","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.37099/mtu.dc.etdr/442","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/10.37099/mtu.dc.etdr/442","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.mtu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.mtu.edu%3Aetdr-1483","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Megan Frost"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Martin Thompson","Smitha Rao"]},{"key":"dc:creator","label":"Author","values":["Kolipaka, Sushant Satyanarayan"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.created","label":"Dc Date Created","values":["2017-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Department of Biomedical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Master's Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science in Biomedical Engineering (MS)"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.37099/mtu.dc.etdr/442","https://digitalcommons.mtu.edu/etdr/442"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Nitric oxide (NO) has been shown to possess many Anti-inflammatory effects. Ascorbic acid which is naturally present in human body is known to react with S-nitrosothiols (RSNO) directly to reduce RSNO to NO and produce free thiol groups, if present in more than millimolar concentration. Higher concentration of ascorbic acid is required because the reduction of RSNO is not caused by ascorbate instead, but instead a decomposed product of ascorbic acid. S-Nitroso-N-Acetylpenicillamine is used as an NO donor. An HPLC method is used for determination of the degradation product of ascorbic acid and simultaneously identifying the compound responsible for NO production from RSNO by running the compound through Nitric Oxide Analyzer. Once the compound is identified it has a potential medical use for NO production. For example, it could provide a means that initiates RSNO decomposition in polymeric biomaterials. Thus, increasing the functionality of the medical device coated with such materials and preventing thrombus formation."]},{"key":"dc:title","label":"Title","values":["IDENTIFICATION OF NITRIC-OXIDE DEGRADATION PRODUCTS OF ASCORBIC ACID"]}]}],"canonical_facts":{"dc:contributor":["Megan Frost"],"dc:contributor.committeemember":["Martin Thompson","Smitha Rao"],"dc:creator":["Kolipaka, Sushant Satyanarayan"],"dc:date.created":["2017-01-01T08:00:00Z"],"dc:description.abstract":["Nitric oxide (NO) has been shown to possess many Anti-inflammatory effects. Ascorbic acid which is naturally present in human body is known to react with S-nitrosothiols (RSNO) directly to reduce RSNO to NO and produce free thiol groups, if present in more than millimolar concentration. Higher concentration of ascorbic acid is required because the reduction of RSNO is not caused by ascorbate instead, but instead a decomposed product of ascorbic acid. S-Nitroso-N-Acetylpenicillamine is used as an NO donor. An HPLC method is used for determination of the degradation product of ascorbic acid and simultaneously identifying the compound responsible for NO production from RSNO by running the compound through Nitric Oxide Analyzer. Once the compound is identified it has a potential medical use for NO production. For example, it could provide a means that initiates RSNO decomposition in polymeric biomaterials. Thus, increasing the functionality of the medical device coated with such materials and preventing thrombus formation."],"dc:identifier":["10.37099/mtu.dc.etdr/442","https://digitalcommons.mtu.edu/etdr/442"],"dc:title":["IDENTIFICATION OF NITRIC-OXIDE DEGRADATION PRODUCTS OF ASCORBIC ACID"],"thesis:degree_discipline":["Department of Biomedical Engineering"],"thesis:degree_level":["Open Access Master's Thesis"],"thesis:degree_name":["Master of Science in Biomedical Engineering (MS)"]},"updated_at":"2026-11-19T08:17:02Z"}